MOV10是一种新型免疫疗法和预后生物标志物,通过调节自细胞的作用,有助于质瘤的发展
Feiyu Wang1,2, Linlin Ruan1,3, Wenbin Yang3
1Jiangxi Key Laboratory of oncology(2024SSY06041), JXHC Key Laboratory of Tumour Metastasis, Jiangxi Cancer Hospital & Institute, The Second Affiliated Hospital of Nanchang Medical College, Nanchang, 330029, Jiangxi, P.R. China.
Scientific reports
|February 18, 2026
概括
MOV10是一种RNA螺旋酶,在质母细胞瘤 (GBM) 中过度表达,并与生存率低下有关. 沉默MOV10抑制了GBM的进展,这表明它是这种侵袭性脑癌的潜在治疗目标.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症基因组学 癌症基因组学
背景情况:
- 质母细胞瘤 (GBM) 是一种具有侵略性的脑瘤,尽管目前的治疗方法,但患者的预后不佳.
- 确定分子驱动因素和治疗点对于改善GBM结果至关重要.
- MOV10是一种RNA螺旋酶,被认为是各种癌症中的瘤基因.
研究的目的:
- 研究MOV10在质母细胞瘤 (GBM) 发病过程中的作用及其作为治疗点的潜力.
- 分析GBM患者数据集中的MOV10表达模式,并将其与临床结果相关联.
- 探索MOV10对GBM细胞行为,免疫相互作用和生存的功能影响.
主要方法:
- 分析TCGA,GEO和CGGA数据集,以评估MOV10表达及其与整体存活时间 (OS) 的相关性.
- 考克斯回归分析以确定MOV10作为一个独立的预后因素.
- 功能性丰富分析以确定与MOV10相关的途径.
- 在体外测试 (免疫光,Transwell,细胞增殖,细胞亡,自) 来评估MOV10敲击的效果.
- 对GBM组织进行临床分析,以验证MOV10过度表达.
主要成果:
- 在GBM中,MOV10显著过度表达,与OS负相关,将其确定为独立的预后风险因素.
- MOV10表达与免疫调节有关,包括免疫细胞透,免疫检查点和免疫治疗反应.
- MOV10 Knockdown 降低了M2巨细胞的迁移和入侵,抑制了GBM细胞的增殖,抑制了类似上皮层-介质细胞过渡 (EMT) 的过程,并通过自细胞调节促进了细胞亡.
结论:
- MOV10在推动质母细胞瘤进展和影响瘤微环境方面发挥着至关重要的作用.
- MOV10是新型质母细胞瘤疗法的一个有前途的分子标.
- 针对MOV10可能会提供一种新的策略,以改善这种致命的大脑癌症患者的治疗结果.
相关概念视频
01:27Tumor Immunotherapy
2.0K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.0K
03:03mTOR Signaling and Cancer Progression
4.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.9K
02:07Tumor Progression
7.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.5K